# Syndax Pharmaceuticals Inc: Form 8-K, filed Mar 18, 2024

- Company: [Syndax Pharmaceuticals Inc](/companies/sndx.md) (CIK 1395937)
- Form: 8-K
- Filed: 2024-03-18
- Accepted by EDGAR: Mar 18, 2024, 07:10 ET
- Period: 2024-03-15
- Accession: 0000950170-24-032514
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1395937/000095017024032514/sndx-20240315.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395937/000095017024032514/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395937/000095017024032514/sndx-20240315.htm

Filed Mar 18, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-032514. Last ingested by Listed: Nov 2, 2026, 16:31 ET. No prices; not investment advice.